Lingdao Capital
Overview
Lingdao Capital is a venture capital firm founded in 2018 that focuses on long-term equity investment opportunities in the Asia-Pacific region, with a primary focus on the biomedical and smart technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shanghai Hanyu Medical Technology | Mar 2021 | Series D Extension | Co-investor |
| Pulse Medical Imaging Technology | Aug 2021 | Series C | Co-investor |
| FJ Dynamics | Oct 2018 | Angel | Co-investor |
| BrioHealth Solutions | Jan 2022 | Series D Extension | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Lingdao Capital based?
Lingdao Capital is headquartered in Shenzhen, China.
When was Lingdao Capital founded?
Lingdao Capital was founded in 2018.
How many portfolio companies does Lingdao Capital have?
Lingdao Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Lingdao Capital's portfolio?
Portfolio companies visible on Caplight include Shanghai Hanyu Medical Technology, Pulse Medical Imaging Technology, FJ Dynamics, BrioHealth Solutions.
What was Lingdao Capital's most recent investment shown here?
Lingdao Capital's most recent investment in this portfolio sample was in BrioHealth Solutions in 2022.
What sectors does Lingdao Capital focus on?
Lingdao Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Mobility, Transportation & Logistics.
What company stages does Lingdao Capital focus on?
Stage focus information for Lingdao Capital is not publicly available.
What is Lingdao Capital's AUM?
Lingdao Capital's assets under management are estimated at over $275.0M.